Biotech firm Windtree Therapeutics announced plans to purchase up to $700 million worth of BNB after the coin reached an all-time high. Based in Pennsylvania and trading on Nasdaq under the ticker WINT, the company aims to include BNB in its balance sheet, having already raised $520 million for this initiative. Windtree intends to partner with the crypto exchange Kraken for asset custody. The firm's CEO emphasized the importance of this strategy for securing additional funding to purchase cryptocurrencies. Currently, BNB holds a $106.9 billion market cap and briefly peaked at $808 before dropping in value. This move aligns Windtree with a growing trend of publicly traded companies acquiring cryptocurrencies to enhance their stock value. Recently, other firms like Nano Labs have also made significant crypto purchases, indicating a broader shift towards digital assets among traditional companies.

Source 🔗